Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US62855J1043
Ticker MYGN
Company MYRIAD GENETICS
Currency $
Price
Aware Investor Index (AII) 0.1202
Recommendation HOLD
P/E 33.39
ROE 13.25 %
Capitalization 3,310,852,000 $
Dividend Yield 0.00 %
P/S 4.39
AII Position 465
P/E Position 447
ROE Position 309
Capitalization Position 647
Dividend Yield Position 629
Sales 753,800,000 $
10-Year Average Earnings 99,152,600 $
Shares Outstanding 72,400,000
Equity 748,100,000 $
Dividend per Share 0 $
Industry Biotechnology
Country United States
MYRIAD GENETICS Investor Relations Web Site http://investor.myriad.com







Sales:

YEAR MONTH AMOUNT
2016 6 753,800,000.00 $
2015 6 723,100,000.00 $
2014 6 778,216,000.00 $
2013 6 613,165,000.00 $

Earnings:

YEAR MONTH AMOUNT
2016 6 125,300,000.00 $
2015 6 80,200,000.00 $
2014 6 176,225,000.00 $
2013 6 147,139,000.00 $
2012 6 112,151,000.00 $
2011 6 100,710,000.00 $
2010 6 152,303,000.00 $
2009 6 84,615,000.00 $
2008 6 47,845,000.00 $
2007 6 -34,962,000.00 $

Equity:

YEAR MONTH AMOUNT
2016 6 748,100,000.00 $
2015 6 662,100,000.00 $
2014 6 718,998,000.00 $
2013 6 728,594,000.00 $
2012 6 635,660,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2016 6 72,400,000
2015 6 74,500,000
2014 6 78,182,000
2013 6 83,327,000
2012 6 86,465,000

 












Bloomberg News for MYRIAD GENETICS:

Feb 10, 2012
Nasdaq Short Interest as of Jan. 31
620 87,737 MYRX MYREXIS INC 171,102 212,920 27,673 MYGN MYRIAD GENETICS 2,889,711 2,829,144 719,834 NABI NABI BIOPHARMA...
Aug 26, 2003
CS First Boston Lowers Myriad Genetics to 'Neutral'
Credit Suisse First Boston downgraded Myriad Genetics (MYGN ) to neutral from outperform. Analyst Mark Augustine says...
Nov 17, 2003
Raising Forecast for Children's Place
estimate: .55 Rationale: See stronger operating income Company: Myriad Genetics (MYGN ) Year ending: Jun-2004 Prior estimate: -1.11 New estimate: -1.34 ...
Feb 7, 2005
Online Extra: Healthy Investment?
5.46 Prostate Cancer VIOLTS (FTPCSX) Myriad Genetics (MYGN) 10.07 Medarex (MEDX) ...
May 22, 2001
Reaping the Bush Dividend
one called Human Genome Sciences (HGSI ), and there's another one called Myriad Genetics (MYGN ). I'm not necessarily recommending those firms as the best ones to look at, but I'm saying...
Aug 9, 2011
U.S. Companies Reporting Earnings on Aug. 9
99.5 0.08 NM Jun MRVC# MRV COMM 0.01 na na 0.01 0.0 Jun MYGN# MYRIAD GENETICS 0.30 0.39 -23.1 0.29 3.4 Jun TICKER ...
Aug 9, 2011
U.S. Companies Reporting Positive EPS Surprises, Aug. 9
2.84 10.66 HPT HOSPITALITY PROP 0.89 0.81 9.9 0.86 3.5 2.45 12.86 MYGN# MYRIAD GENETICS 0.30 0.39 -23.1 0.29 3.4 1.07 5.97 TNGN# TENGION INC...
Aug 8, 2011
Implied Stock-Price Moves for U.S. Companies Reporting Results
53 7.22 08/09 Bef-mkt FOSL FOSSIL INC 1.02 8.44 8.30 08/09 Aft-mkt MYGN MYRIAD GENETICS 1.02 9.71 9.54 08/09 SPWRA SUNPOWER CORP-A ...
Jun 22, 2007
Stocks: Eleven Cash-Flow Champs
14.83 Myriad Genetics (MYGN) 36.64 ...
Dec 14, 2006
S&P Ups Oracle to Strong Buy
reflecting a multiple reduction due to the aforementioned sales risks. Myriad Genetics (MYGN): Cuts to 3 STARS (hold) from 4 STARS (buy) Analyst: Paul Starsia Our downgrade comes...


Google News for MYRIAD GENETICS:

StreetInsider.com - 1 day ago
Myriad Genetics (MYGN) Granted FDA Acceptance for ...
Myriad Genetics (MYGN) Granted FDA Acceptance for BRACAnalysis CDx® Supplementary PMA to Review Companion Diagnostic for ...
StockNewsGazette - 4 hours ago
What the Insider Data Suggests About Myriad Genetics, Inc. (MYGN)
Recent insider trends for Myriad Genetics, Inc. (NASDAQ:MYGN) have caught the attention of investors. Analysts monitor insider data to ...
Equities.com (blog)
Myriad Genetics (MYGN) PT Raised to $27 at Piper Jaffray
Piper Jaffray raised its price target on Myriad Genetics (NASDAQ: MYGN) to $27.00 (from $19.00) while maintaining a Neutral rating.
The Ledger Gazette
GeneSight® Shown to Statistically Significantly Improve Generalized ...
SALT LAKE CITY, Oct. 19, 2017 (GLOBE NEWSWIRE) -- Assurex Health, a wholly-owned subsidiary of Myriad Genetics, Inc. (NASDAQ:MYGN), ...
BZ Weekly
Market Check: Zooming in on the Technicals for Myriad Genetics Inc ...
The Percentage Price Oscillator has been recently spotted below the signal line on shares of Myriad Genetics Inc (MYGN). Traders watching ...
StreetInsider.com - 3 days ago
UPDATE: Leerink Partners Initiaties Myriad Genetics (MYGN) at ...
Leerink Partners initiates coverage on Myriad Genetics (NASDAQ: MYGN) with a Market Perform rating and a price target of $31.00.
The Ledger Gazette
Trending Higher or Stalling Out? Stock Update on Myriad Genetics ...
In the latest session, Myriad Genetics Inc (MYGN) moved -1.40%, touching a recent bid of 34.44. Current price levels place the shares above ...
WeeklyHub
Setting Up Technical Traps: Myriad Genetics, Inc. (MYGN), Marathon ...
Myriad Genetics, Inc. (NASDAQ:MYGN) trades at $34.44 having a market capitalization of $2.36 billion. MYGN stock price climbed 72.98% over ...
StockNewsTimes
Are These Good Stocks for Value Investors? – Marathon Patent ...
Myriad Genetics, Inc. (NASDAQ:MYGN) is another stock that is grabbing investors attention these days. Its shares have trimmed -7.67% since ...
GlobeNewswire (press release) - 6 hours ago
Looking at Myriad Genetics Inc (MYGN)'s Levels: What's Inside the ...
Currently, the 14-day Commodity Channel Index (CCI) for Myriad Genetics Inc (MYGN) is sitting at -248.32. CCI is an indicator used in technical ...


Back